Stephane Bancel, Chief Executive Officer at Moderna, Inc. (MRNA), sold 137,800 shares at $148.21 ($20.5M) on 2023-03-29, disclosed to the SEC on 2023-03-31.
Seasonal sale ($20.5M) by Chief Executive Officer — this insider has traded MRNA in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $148.21 | 31,349 | $4.6M | 22.7% |
| 2 | $148.21 | 31,349 | $4.6M | 22.7% |
| 3 | $148.83 | 8,300 | $1.2M | 6.0% |
| 4 | $149.72 | 351 | $53K | 0.3% |
| 5 | $149.72 | 351 | $53K | 0.3% |
| 6 | $147.13 | 13,900 |
| $2.0M |
| 10.0% |
| 7 | $148.24 | 2,979 | $442K | 2.2% |
| 8 | $148.24 | 2,979 | $442K | 2.2% |
| 9 | $149.39 | 15,965 | $2.4M | 11.6% |
| 10 | $149.39 | 15,965 | $2.4M | 11.6% |
| 11 | $149.99 | 7,156 | $1.1M | 5.2% |
| 12 | $149.99 | 7,156 | $1.1M | 5.2% |
| Total | $148.61 avg | 137,800 | $20.5M | 100% |
| Filing → |
| MRNA | SELL | 2024-02-16 | $4.7M | — | Filing → |
| MRNA | SELL | 2023-06-30 | $6.6M | — | Filing → |
| MRNA | SELL | 2023-06-23 | $19.3M | — | Filing → |